Retrospective trial of long acting analogues detemir and degludec usage in children and adolescents to overcome glucose variability caused by dawn phenomenon and reverse dawn phenomenon
Backgraund: Children with type 1 diabetes mellitus (T1DM) need more insulin late in the evening (reverse dawn phenomenon (RDP)), and adolescents need more insulin yearly in the morning (dawn phenomenon (DP)); these cause blood glucose variability. Modern long acting insulin analogues allow to achiev...
Guardado en:
Autores principales: | A. V. Vitebskaya, E. V. Shreder, A. V. Popovich, E. A. Pisareva |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8bdb00b969054838846ebac90b50d87d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases
por: Meng-Yi Luo, et al.
Publicado: (2021) -
False Dawn
por: Mohamed Aslam Haneef
Publicado: (1998) -
1,5-anhydroglucitol in diabetes: its role in diagnostics, screening, glycemic status assessment, and the prediction of complications
por: V. V. Klimontov, et al.
Publicado: (2020) -
Insulin degludec is a new ultra-long-acting insulin analogue
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014) -
Economic classifications at the dawn of the new millennium
Publicado: (2017)